comprehensive genomic profiles small cell lung cancer
sequenced genomes small cell lung cancers sclc one deadliest human cancers nearly tumours analysed found bi-allelic inactivation tp53 rb1 sometimes complex genomic rearrangements two tumours wild-type rb1 evidence chromothripsis leading overexpression cyclin d1 encoded ccnd1 gene revealing alternative mechanism rb1 deregulation thus loss tumour suppressors tp53 rb1 obligatory sclc discovered somatic genomic rearrangements tp73 create oncogenic version gene tp73dex2/ rare cases sclc tumours exhibited kinase gene mutations providing possible therapeutic opportunity individual patients finally observed inactivating mutations notch family genes % human sclc accordingly activation notch signalling pre-clinical sclc mouse model strikingly reduced number tumours extended survival mutant mice furthermore neuroendocrine gene expression abrogated notch activity sclc cells first comprehensive study somatic genome alterations sclc uncovers several key biological processes identifies candidate therapeutic targets highly lethal form cancer
